S1P receptor modulators for treating multiple sclerosis

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

HIESTAND, Peter C.,SCHNELL, Christian

申请号：

AU2018202210

公开号：

AU2018202210A1

申请日:

2018.03.28

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

#$%^&*AU2018202210A120180426.pdf#####C: NRPortbl DCC REC 4881025_1.DOC-1/23/2013 ABSTRACT The present invention relates uses of an S1 P receptor modulator such as 2-substituted 2amino- propane-1,3-diol or 2-amino-propanol derivatives, e.g. a compound comprising a group of formula (X) z R3zR 2zN CH2R 1 (X) for the treatment or prevention of neo-angiogenesis associated with a demyelinating disease, e.g. multiple sclerosis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/